Market Overview

Mid-Afternoon Market Update: Avis Climbs Following Deal With Waymo; Neothetics Shares Plunge


Toward the end of trading Monday, the Dow traded up 0.19 percent to 21,434.44 while the NASDAQ declined 0.21 percent to 6,251.93. The S&P also rose, gaining 0.11 percent to 2,441.00.

Leading and Lagging Sectors

Utilities shares rose by 0.85 percent in the US market on Monday. Top gainers in the sector included American Midstream Partners LP (NYSE: AMID), RGC Resources Inc. (NASDAQ: RGCO), and FirstEnergy Corp. (NYSE: FE).

In trading on Monday, technology shares fell by 0.25 percent. Meanwhile, top losers in the sector included Numerex Corp. (NASDAQ: NMRX), down 8 percent, and RealNetworks Inc (NASDAQ: RNWK), down 7 percent.

Top Headline

U.S. durable goods orders declined 1.1 percent for May. However, economists were expecting a 0.6 percent drop for May.

Durable goods orders, ex-transportation, rose 0.10percent, while core capital-goods orders slipped 0.2 percent in May.

Equities Trading UP

Avis Budget Group Inc. (NASDAQ: CAR) shares shot up 11 percent to $26.82 after the company disclosed that it has formed a partnership with Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL)’s autonomous car business, Waymo. Under a multi-year agreement, Avis will service and store 600 of Waymo’s self-driving cars. The fleet is part of Waymo’s test program in Phoenix, Arizona. The arrangement solves a key problem faced by companies working to incorporate autonomous cars into ride-hailing services.

Shares of Sparton Corporation (NYSE: SPA) got a boost, shooting up 21 percent to $22.13 as Ultra Electronics confirmed that it is in advanced discussions to acquire the company.

VOXX International Corp (NASDAQ: VOXX) shares were also up, gaining 13 percent to $8.90 as the company agreed to sell Hirschmann Car Communication to TE Connectivity for $166 million.

Equities Trading DOWN

Matinas BioPharma Holdings Inc (NASDAQ: MTNB) shares dropped 21 percent to $2.20. Matinas BioPharma reported that Phase 2 clinical study of orally-administered MAT2203 for the treatment of vulvovaginal candidiasis did not meet expectations.

Shares of Neothetics Inc (NASDAQ: NEOT) were down 70 percent to $0.710. Neothetics disclosed that LIPO-202 did not show any improvement on efficacy measurements.

Stratasys, Ltd. (NASDAQ: SSYS) was down, falling around 12 percent to $24.43. Goldman Sachs downgraded Stratasys from Neutral to Sell.


In commodity news, oil traded up 0.70 percent to $43.31 while gold traded down 0.80 percent to $1,246.30.

Silver traded down 0.37 percent Monday to $16.645, while copper rose 0.11 percent to $2.6375.


European shares closed higher today. The eurozone’s STOXX 600 gained 0.37 percent, the Spanish Ibex Index rose 0.62 percent, while Italy’s FTSE MIB Index jumped 0.81 percent. Meanwhile the German DAX climbed 0.29 percent, and the French CAC 40 surged 0.56 percent while U.K. shares rose 0.31 percent.


U.S. durable goods orders declined 1.1 percent for May. However, economists were expecting a 0.6 percent drop for May. Core capital-goods orders slipped 0.2 percent in May.

The Chicago Fed National Activity Index dropped to a reading of -0.26 in May, compared to a reading of +0.57 in April.

The Dallas Fed manufacturing business index slipped to 15.00 in June, versus a prior reading of 17.20. Economists were expecting a reading of 16.00.

Posted-In: M&A News Eurozone Commodities Global Intraday Update Markets Movers


Related Articles (CAR + AMID)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at